Newsroom
Filters: Value added medicines
x
Access to generic and biosimilar medicines can be improved with coherent proposals for IP […]
Read moreThe European Parliament Own Initiative Report on an intellectual property […]
Read moreInnovation on existing, well-known molecules through repurposing can deliver huge benefits for patients and address unmet medical needs sustainably. Today […]
Read more“Digitalisation the key to efficient EU pharmaceutical regulation and easing […]
Read moreGenerics And Biosimilars Must Become A Central Policy Pillar, Says […]
Read more